I hardly think its a 'dangerous time' not to be in OCAT. Fact of the matter is they are going to raise funds via dilution. And whether it's via a stock offering or through untapped LP shares, I see that pressure applying instantly to the pps. That's the risk of investing in small biotech though. Oh well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.